Company Quick10K Filing
Remsleep Holdings
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-12
10-Q 2020-03-31 Filed 2020-05-18
10-K 2019-12-31 Filed 2020-04-10
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-15
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-17
10-Q 2018-03-31 Filed 2018-06-28
10-K 2017-12-31 Filed 2018-06-28
10-Q 2017-09-30 Filed 2018-02-06
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-18
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2017-02-23
10-Q 2016-06-30 Filed 2017-02-22
10-Q 2016-03-31 Filed 2017-02-22
10-K 2015-12-31 Filed 2017-02-15
10-Q 2015-09-30 Filed 2017-01-04
10-Q 2015-06-30 Filed 2016-12-30
10-Q 2015-03-31 Filed 2016-12-30
10-K 2014-12-31 Filed 2016-04-14
10-Q 2014-06-30 Filed 2015-03-02
10-Q 2014-06-30 Filed 2015-03-02
10-Q 2014-03-31 Filed 2015-02-25
10-K 2013-12-31 Filed 2015-02-04
10-Q 2013-09-30 Filed 2013-12-03
10-Q 2013-06-30 Filed 2013-08-26
10-Q 2013-03-31 Filed 2013-06-27
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-04-15
10-Q 2010-09-30 Filed 2010-11-22
10-Q 2010-06-30 Filed 2010-08-12
10-Q 2010-03-31 Filed 2010-05-18
10-K 2009-12-31 Filed 2010-04-07
8-K 2020-01-30
8-K 2020-01-27
8-K 2018-07-26
8-K 2018-01-29

Remsleep Holdings Financials

RMSL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash46641901019010000000002521411744182102
Accounts Receivable
Inventory
PP&E141414151413131312151515223238626374
Assets57121025010-020191919191818132091841182448557113273197
Accounts Payable141155142142211214222226226226226226226226226226229240243243244240249241241
Long-Term Debt182311250
Liabilities460151047159211,1201,3123,4663,8373,4103634014013143373403403313703926814894836336371,2341,3451,096
Stockholders' Equity1112-5-79-714-921-1,120-1,312-3,466-3,837-3,410-343-382-381-295-318-321-322-319-351-383-498-371-239-548-580-1,121-1,072-899
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000
Cost of Revenue00000000
Gross Profit00000000
R&D
SG&A71164-63267384598161844
Tax00000000000000000000000000
Net Income-18,923-17-55-1,244-206-370-198-2,138-861428-34-39-0-57-26-3-0-415-389-48-453-162-308-349-592-2,347-77
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-64-1750-54-42-784-71-34-380-56-26-0-19-23-27-25-42-56-52
Cash Investing-100030-3300-7-19-24-2-27
Cash Financing2415-232042784403605823601939201978-88494196-1